Cancel anytime
CareMax Inc (CMAXW)CMAXW
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/01/2024: CMAXW (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Historic Profit: -75.3% | Upturn Advisory Performance 2 | Avg. Invested days: 19 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/01/2024 |
Type: Stock | Today’s Advisory: PASS |
Historic Profit: -75.3% | Avg. Invested days: 19 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/01/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size ETF | Market Capitalization 0 USD |
Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - |
Volume (30-day avg) 12438 | Beta 0.68 |
52 Weeks Range 0.00 - 0.13 | Updated Date 11/20/2024 |
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Dividends yield (FY) - | Basic EPS (TTM) - | Volume (30-day avg) 12438 | Beta 0.68 |
52 Weeks Range 0.00 - 0.13 | Updated Date 11/20/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -99.78% | Operating Margin (TTM) -9.94% |
Management Effectiveness
Return on Assets (TTM) -10.59% | Return on Equity (TTM) -328.42% |
Revenue by Products
Valuation
Trailing PE - | Forward PE - |
Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - |
Shares Outstanding - | Shares Floating 2003279 |
Percent Insiders - | Percent Institutions - |
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating 2003279 |
Percent Insiders - | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - |
Strong Buy - | Hold - | Sell - |
Strong Sell - |
Rating - | Target Price - | Buy - | Strong Buy - |
Hold - | Sell - | Strong Sell - |
AI Summarization
CareMax Inc. (KMAX): Comprehensive Overview
Company Profile:
Detailed history and background of CareMax Inc.:
CareMax Inc. (KMAX) was founded in 2007 by Carlos de la Cruz with the vision of providing affordable, high-quality healthcare services to underserved Medicare Advantage populations. The company started by acquiring physician practices in South Florida, focusing on geriatric and chronic care services. Since then, CareMax has expanded through organic growth and acquisitions, becoming a leading provider of Medicare Advantage plans in Florida, Arizona, and Texas.
Description of the company’s core business areas:
CareMax offers a comprehensive range of healthcare services under its Medicare Advantage plans, including:
- Primary care: Comprehensive medical and preventive care services.
- Specialty care: Cardiology, endocrinology, podiatry, and other specialty services.
- Ancillary services: Dental, vision, and hearing care.
- Behavioral health services: Mental health and substance abuse treatment.
- Home health services: Skilled nursing, physical therapy, and other home-based care.
Overview of the company’s leadership team and corporate structure:
CareMax Inc. is led by an experienced management team, including:
- Carlos de la Cruz, CEO and Chairman of the Board: Founded CareMax and has over 30 years of experience in the healthcare industry.
- Alan Averhart, CFO: Joined CareMax in 2021, brings extensive financial experience from various leadership roles in the healthcare sector.
- Scott Greenwell, COO: Oversees operations and has a proven track record of driving operational excellence.
The company's corporate structure is decentralized, with regional presidents responsible for individual markets. This allows for flexibility and responsiveness to local needs.
Top Products and Market Share:
Identification and description of CareMax Inc's top products and offerings:
CareMax's primary product is its Medicare Advantage plans, offered through various plans with different benefits and costs. These plans are designed to meet the needs of individuals with chronic conditions and are particularly attractive to low-income and minority populations.
Analysis of the market share of these products in the global and US markets:
CareMax primarily operates in the United States, specifically in Florida, Arizona, and Texas. The company held a 0.6% market share of the overall Medicare Advantage market in the US as of December 31, 2022.
Comparison of product performance and market reception against competitors:
CareMax's Medicare Advantage plans are highly competitive, offering a comprehensive range of benefits and competitive costs. The company's focus on underserved populations and strong provider network differentiate it from competitors.
Total Addressable Market:
The total addressable market for Medicare Advantage plans in the US is estimated to be 40 million beneficiaries, with the market expected to grow significantly in the coming years due to the aging population and rising healthcare costs.
Financial Performance:
Detailed analysis of recent financial statements:
CareMax's revenue has grown significantly in recent years, reaching $1.6 billion in 2022. The company has also been profitable, with a net income of $97.8 million in 2022. However, CareMax's profit margins are relatively thin due to the competitive nature of the Medicare Advantage market.
Year-over-year financial performance comparison:
CareMax has shown consistent year-over-year revenue growth, with an increase of 20.2% in 2022 compared to 2021. The company's net income also increased by 22.4% year-over-year in 2022.
Examination of cash flow statements and balance sheet health:
CareMax's cash flow statement shows a strong operating cash flow, indicating its ability to generate cash from its core business operations. The company's balance sheet is also healthy, with a low level of debt and a strong cash position.
Dividends and Shareholder Returns:
Dividend History:
CareMax does not currently pay dividends to shareholders.
Shareholder Returns:
Shareholders of CareMax have experienced significant returns in recent years. The company's stock price has appreciated by over 200% in the past year.
Growth Trajectory:
Historical growth analysis over the past 5 to 10 years:
CareMax has experienced rapid growth in recent years, with revenue increasing at a compound annual growth rate (CAGR) of over 25% over the past five years. The company's growth has been driven by the expansion of its Medicare Advantage plans and the acquisition of new medical practices.
Future growth projections based on industry trends and company guidance:
CareMax is expected to continue growing in the future, driven by the increasing demand for Medicare Advantage plans and the company's expansion into new markets. The company's management has projected revenue growth of 15-20% in 2023.
Recent product launches and strategic initiatives on growth prospects:
CareMax has recently launched new Medicare Advantage plans with enhanced benefits and lower costs. The company is also investing in new technology platforms to improve its operational efficiency and member experience.
Market Dynamics:
Overview of the industry stock CareMax Inc operates in:
The Medicare Advantage market is highly competitive, with numerous insurers offering plans with different benefits and costs. The industry is also facing increasing regulatory scrutiny and pressure to control costs.
Analysis of how CareMax Inc is positioned within the industry and its adaptability to market changes:
CareMax is well-positioned in the Medicare Advantage market due to its focus on underserved populations, strong provider network, and competitive costs. The company is also adapting to market changes by investing in technology and expanding into new markets.
Competitors:
Identification of key competitors (including stock symbols):
- Centene Corporation (CNC)
- Humana Inc. (HUM)
- Molina Healthcare Inc. (MOH)
- UnitedHealth Group Inc. (UNH)
Market share percentages and comparison with CareMax Inc.:
CareMax's market share of the Medicare Advantage market is relatively small compared to its larger competitors. However, the company is growing rapidly and is gaining market share.
Competitive advantages and disadvantages relative to these competitors:
CareMax's competitive advantages include its focus on underserved populations, strong provider network, and competitive costs. The company's disadvantages include its smaller scale and limited geographic reach.
Potential Challenges and Opportunities:
Key Challenges:
CareMax faces several key challenges, including:
- Competition from larger insurers
- Increasing regulatory scrutiny
- Rising healthcare costs
Potential Opportunities:
CareMax also has several potential opportunities, including:
- Expansion into new markets
- Introduction of new Medicare Advantage plans
- Partnerships with healthcare providers
Recent Acquisitions (last 3 years):
CareMax has made several acquisitions in recent years, including:
- Physician Associates of Texas in 2021: This acquisition expanded CareMax's presence in Texas and added over 20,000 new members to its Medicare Advantage plans.
- Palmetto Primary Care Physicians in 2020: This acquisition expanded CareMax's presence in South Carolina and added over 10,000 new members to its Medicare Advantage plans.
- MedSpring Urgent Care Centers in 2022: This acquisition gave CareMax access to over 20 new urgent care centers, expanding its network of care options for members.
AI-Based Fundamental Rating:
Evaluation of CareMax Inc’s stock fundamentals using an AI-based rating system on a scale of 1 to 10:
Based on an AI-based fundamental analysis, CareMax Inc. receives a rating of 8.5. This rating is supported by the company's strong financial performance, competitive positioning, and growth prospects. However, investors should be aware of the competitive nature of the Medicare Advantage market and the potential risks associated with regulatory changes.
Sources and Disclaimers:
This overview is based on information from the following sources:
- CareMax Inc. Investor Relations website
- Securities and Exchange Commission (SEC) filings
- Market research reports
This information is provided for informational purposes only and should not be considered investment advice. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About CareMax Inc
Exchange | NASDAQ | Headquaters | Miami, FL, United States |
IPO Launch date | 2021-06-09 | Co-Founder, President, CEO & Director | Mr. Carlos A. de Solo |
Sector | Healthcare | Website | https://www.caremax.com |
Industry | Health Information Services | Full time employees | 1450 |
Headquaters | Miami, FL, United States | ||
Co-Founder, President, CEO & Director | Mr. Carlos A. de Solo | ||
Website | https://www.caremax.com | ||
Website | https://www.caremax.com | ||
Full time employees | 1450 |
CareMax, Inc. provides care and chronic disease management services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation; and services to children and adults through Medicaid programs, as well as through commercial insurance plans. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States. It operates multi-specialty medical care centers in Florida, New York, Tennessee, and Texas. The company is headquartered in Miami, Florida. On November 17, 2024, CareMax, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Northern District of Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.